[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634731":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":10,"centralContacts":21,"locations":10,"responsibleParty":27,"collaborators":10,"id":29,"slug":30,"hasResults":31,"nctId":32,"briefTitle":33,"officialTitle":34,"acronym":10,"eligibilityCriteria":35,"healthyVolunteers":31,"sex":36,"minAge":37,"maxAge":10,"enrollmentInfo":38,"targetDuration":10,"studyType":41,"phases":10,"briefSummary":42,"conditions":43,"keywords":45,"overallStatus":47,"whyStopped":10,"lastUpdateSubmitDate":48,"lastUpdatePostDateStruct":49,"startDateStruct":52,"completionDateStruct":54,"leadSponsor":56,"locationsCount":10},{"fullName":5,"class":6},"Prenosis, Inc.","INDUSTRY",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Adult patients at risk of clinically significant events",null,{"label":12,"type":10,"description":10,"interventionNames":13},"Adult patients suspected of sepsis",[14],"Diagnostic Test: Sepsis ImmunoScore",[16],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"DIAGNOSTIC_TEST","Sepsis ImmunoScore","The Sepsis ImmunoScore is a risk stratification tool that uses Artificial Intelligence\u002FMachine Learning to aid in the identification of patients likely to have or progress to sepsis within 24 hours of assessment.",[12],[22],{"name":23,"role":24,"phone":25,"phoneExt":10,"email":26},"Grace Staples","CONTACT","(312) 235-3580","grace.staples@prenosis.com",{"type":28,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100634731","performance-and-impact-of-the-sepsis-immunoscore-100634731",false,"NCT07543497","Performance and Impact of the Sepsis ImmunoScore","Clinical Utility and Performance of the Sepsis ImmunoScore: A Prospective Cohort Device Study","Inclusion Criteria:\n\n* Adult (age 18 years or older) patients presenting to hospitals and emergency departments of medical institutions across the United States.\n* Adult (age 18 years or older) patients suspected of sepsis.\n\nExclusion Criteria:\n\n* none","ALL","18 Years",{"count":39,"type":40},5000,"ESTIMATED","OBSERVATIONAL","The goal of this prospective cohort device study is to assess clinical usage and impact, diagnostic performance, and prognostic performance of the Sepsis ImmunoScore.",[44],"Sepsis",[46],"sepsis","NOT_YET_RECRUITING","2026-04-15",{"date":50,"type":51},"2026-04-22","ACTUAL",{"date":53,"type":40},"2026-04",{"date":55,"type":40},"2027-12",{"name":5,"class":6}]